THE BioMed Co., Ltd. (KOSDAQ:214610)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,970.00
-330.00 (-7.67%)
At close: Oct 10, 2025

Revenue by Product

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Biochemical Diagnostics
2.92B
Log In
Log In
Log In
Log In
Upgrade
Biochemical Diagnostics Growth
-9.54%
Log In
Log In
Log In
Log In
Upgrade
Molecular Diagnostics
1.01B
Log In
Log In
Log In
Log In
Upgrade
Molecular Diagnostics Growth
-40.61%
Log In
Log In
Log In
Log In
Upgrade
Immunodiagnostics
462.86M
Log In
Log In
Log In
Log In
Upgrade
Immunodiagnostics Growth
11.84%
Log In
Log In
Log In
Log In
Upgrade
Other
255.45M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
597.20%
Log In
Log In
Log In
Log In
Upgrade
Other
255.45M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
597.20%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
1.69B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-22.54%
Log In
Log In
Log In
Log In
Upgrade
America
4.94B
Log In
Log In
Log In
Log In
Upgrade
America Growth
3986.09%
Log In
Log In
Log In
Log In
Upgrade
South Korea
2.10B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-8.40%
Log In
Log In
Log In
Log In
Upgrade
Europe
939.57M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
21.86%
Log In
Log In
Log In
Log In
Upgrade
Other
1.69B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-22.54%
Log In
Log In
Log In
Log In
Upgrade